Merkel Miracle
March 24, 2017
Category: Home
Tags: Untagged

Today's approval of avelumab by the US Food and Drug Administration (FDA) is the first for a treatment of Merkel cell carcinoma (MCC), a rare and aggressive form of skin cancer.  "While skin cancer is one of the most common cancers, MCC patients have not had an approved treatment option until now," said Richard Pazdur, MD, acting director of the Office of Hematology and Oncology Products in the FDA's Center for Drug Evaluation and Research and director of the FDA's Oncology Center of Excellence, read full article here.

Taking Care of Tidewater ~ See the Difference with Us!